blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4222502

EP4222502 - A METHOD FOR DETERMINING THE LEVEL OF VITAMIN D AND METABOLITES THEREOF [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  07.07.2023
Database last updated on 26.07.2024
FormerThe international publication has been made
Status updated on  08.04.2022
Formerunknown
Status updated on  15.10.2021
Most recent event   Tooltip01.12.2023Change: Validation statespublished on 03.01.2024  [2024/01]
01.12.2023Change - extension statespublished on 03.01.2024  [2024/01]
Applicant(s)For:AL  AT  BE  BG  CH  CY  CZ  DK  EE  ES  FI  FR  GB  GR  HR  HU  IE  IS  IT  LI  LT  LU  LV  MC  MK  MT  NL  NO  PL  PT  RO  RS  SE  SI  SK  SM  TR 
F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
For:DE 
Roche Diagnostics GmbH
Sandhofer Strasse 116
68305 Mannheim / DE
[2023/32]
Inventor(s)01 / BAECHER, Silvia
81477 München Süd / DE
02 / GEISTANGER, Andrea
81477 München Süd / DE
03 / GRUBER, Dominik
81477 München Süd / DE
04 / JOSEL, Hans-Peter
82377 Penzberg / DE
 [2023/32]
Representative(s)Epping, Claudia Viktoria
Roche Diagnostics GmbH
Patentabteilung (LPP.....6164)
Nonnenwald 2
82377 Penzberg / DE
[2023/32]
Application number, filing date21783252.627.09.2021
[2023/32]
WO2021EP76462
Priority number, dateEP2020019900029.09.2020         Original published format: EP 20199000
[2023/32]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2022069392
Date:07.04.2022
Language:EN
[2022/14]
Type: A1 Application with search report 
No.:EP4222502
Date:09.08.2023
Language:EN
The application published by WIPO in one of the EPO official languages on 07.04.2022 takes the place of the publication of the European patent application.
[2023/32]
Search report(s)International search report - published on:EP07.04.2022
ClassificationIPC:G01N33/82
[2023/32]
CPC:
G01N33/82 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/32]
TitleGerman:VERFAHREN ZUR BESTIMMUNG DES VITAMIN-D-SPIEGELS UND METABOLITEN DAVON[2023/32]
English:A METHOD FOR DETERMINING THE LEVEL OF VITAMIN D AND METABOLITES THEREOF[2023/32]
French:PROCÉDÉ DE DÉTERMINATION DU TAUX DE VITAMINE D ET DE SES MÉTABOLITES[2023/32]
Entry into regional phase02.05.2023National basic fee paid 
02.05.2023Designation fee(s) paid 
02.05.2023Examination fee paid 
Examination procedure02.05.2023Examination requested  [2023/32]
02.05.2023Date on which the examining division has become responsible
09.11.2023Amendment by applicant (claims and/or description)
Fees paidRenewal fee
20.09.2023Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XA]EP0036145  (INTERX RESEARCH CORP [US]) [X] 14 * Example III *[A] 1-13,15;
 [Y]WO02057797  (QUEST DIAGNOSTICS INC [US]) [Y] 1-15 * claims 1, 19, 66; p. 10 *;
 [Y]US2014273021  (ZIELINSKI JOHN F [US], et al) [Y] 1-15 * introduction; par. 6 *;
 [Y]WO2016091755  (HOFFMANN LA ROCHE [CH], et al) [Y] 1-15 * par. 111 *
by applicantUS7087395
 US2010068725
    - Clinical Biochemistry, (20120000), vol. 45, pages 1491 - 1496
    - VARSHNEY et al., "Ligand Binding Strategies of Human Serum Albumin", Chirality, (20100000), vol. 22, pages 80 - 81
 EP20200199000
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.